Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyHematologic NeoplasmsProtocol groupAcute LeukemiasMyeloproliferative neoplasms (MPN) and myelodysplastic neoplasms (MDS)TransplantationDiseaseAcute Myeloid LeukemiaMyelodysplastic NeoplasmsStem Cell Transplantation, AllogeneicSubgroupICD10C92.0-C92.5-C92.6-C92.7-C92.8-C92.9-C93.0-D46.-MeSHLeukemia, Myeloid, AcuteMyelodysplastic SyndromesSequenceChemotherapyChemo-substanceAzacitidineLenalidomideChemo-substanceAzacitidineLenalidomideChemo-substanceAzacitidineLenalidomideChemo-substanceAzacitidineLenalidomideNo. Substances12 RadiotherapySupportive therapySupportive substanceCiprofloxacinGranisetronPosaconazoleSupportive substanceCiprofloxacinGranisetronPosaconazoleSupportive substanceCiprofloxacinGranisetronPosaconazoleSupportive substanceCiprofloxacinGranisetronPosaconazoleNo. Substances3Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationRelapse therapyTherapy phaseTherapy intentioncurative or palliativepalliativeRisksEmetogenicity (MASCC/ESMO)Febrile NeutropeniaHyperbilirubinemiaInfectionsNeutropeniaPainPneumoniaRenal FailureSepsisThrombocytopenia below 50 000/µl only studiesPublicationAuthorCraddock CLübbert MPlatzbecker USchroeder TDiseaseAML- oder CMML-Rezidiv nach allogener StammzelltranplantationAML- oder MDS-Rezidiv nach allogener StammzelltranplantationDrohendes AML- oder MDS-Rezidiv nach allogener Stammzelltranplantation (Spenderchimärismus <80%)OriginCarl Gustav Carus Technical University of Dresden, Dresden, Germany, RELAZA trialDivision Hematology and Oncology, University of Freiburg Medical Center, Freiburg, GermanyOncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, GermanyUniversity of Birmingham, Birmingham, United KingdomProtocols in Revision 4 protocols foundProtocols under revision.Azacitidine 100, Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation (PID2302 V1.0)Azacitidine 100, Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation, Variant 1. (PID2320 V1.0)Azacitidine 75 / Lenalidomide 25, Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation (PID827 V1.2)Azacitidine 75, Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation. (PID2327 V1.0)
